Full-Time

Lead Project Manager

Ecoa

Posted on 11/6/2024

Clairo

Clairo

5,001-10,000 employees

Clinical evidence generation for trials

No salary listed

Senior

Remote in USA

Category
Project Management
Business & Strategy
Requirements
  • Bachelor’s degree and proven Project Management skills or experience within the industry, including expertise in primary service line and/or support of studies in multiple service lines.
  • Demonstrated ability to mentor staff.
  • 5-10 years of experience in pharmaceutical field (or related industry experience), with an emphasis on project management.
  • Knowledge of the drug development process.
  • Ideally experience within eCOA or similar industry products.
  • Software Development Life Cycle (SDLC) experience.
  • Excellent organizational, interpersonal, time management, and prioritization skills.
  • Excellent verbal and written communication skills, including ability to communicate effectively in English.
  • Working knowledge of Microsoft Office products.
  • Detail oriented and demonstrated responsiveness to inquiries and requests.
  • Valid passport and ability to travel approximately 20%.
Responsibilities
  • Manage designated Project Management staff, which includes:
  • Mentoring and defining career paths by developing core competencies.
  • Ensuring proper training is executed and documented.
  • Conducting reviews of system set-ups and documents to ensure high quality of deliverables in accordance with quality standards and SOPs.
  • Coordinating routine status meetings to facilitate communications, monitor workload, and provide forecasting guidance.
  • Collecting and monitoring defined staff metrics.
  • Independently lead the Planning and Setup, Monitoring, and Closeout phases of program/study management which includes:
  • Gathering customer requirements and relaying to internal teams.
  • Developing study documentation.
  • Distributing/tracking equipment.
  • Creating/distributing reports.
  • Archiving study data and documentation.
  • Appropriate setting and fulfilling of customer expectations.
  • Monitor study timelines and manage the financial components of each program/study, which includes:
  • Budget reviews.
  • Revenue forecasting.
  • Scope changes.
  • Invoice reconciliation.
  • Identify potential study risks and mitigations, and escalate as appropriate.
  • Manage internal/external negotiations and promote collaboration to foster a positive team environment, effective communications, and efficient use of resources to meet study timelines and contractual obligations.
  • Develop and apply problem solving strategies to address customer issues and maintain issue tracking documentation to monitor progress and ensure timely resolution to customer escalations.
  • Provide primary service line support to cross-trained team members from other service lines
  • May serve as point of contact for focus areas within service lines
  • Influence strategic decision making and implement departmental objectives according to schedule
  • Serve as department lead for operational readiness regarding new product initiatives as applicable within Line of Business
  • May guide study teams in being consistent across Therapeutic Area or Program as pertinent to ensure customer is consistent in study set up, optimizing efficiencies and following customer program objectives
  • Ensure compliance with timely training completion/documentation
  • Present study services at Investigator Meetings or site initiation meetings as needed
  • Attend client meetings with Business Development and/or Operational teams to present Company services and Operational Data flow, as needed and participate in sales initiatives to generate incremental revenue
  • Assist with developing training plans and training new members of the Project Management team
  • Perform other duties, assignments, or special projects as time and/or circumstances necessitate

Clario specializes in generating clinical evidence for medical research by combining scientific expertise with a wide range of endpoint technology. Their products support various types of clinical trials, including decentralized, hybrid, and site-based trials, allowing for flexibility in how studies are conducted. Clario stands out from competitors due to its extensive experience, having participated in nearly 19,000 clinical trials and achieved 870 regulatory approvals, which provides a high level of reliability in the data they produce. The company's goal is to empower partners in the healthcare industry to improve patient outcomes by providing comprehensive and trustworthy clinical evidence.

Company Size

5,001-10,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$29.9M

Headquarters

London, United Kingdom

Founded

1972

Simplify Jobs

Simplify's Take

What believers are saying

  • Clario's acquisition of NeuroRx enhances its neuroscience capabilities in multiple sclerosis imaging.
  • FDA clearance of SpiroSphere® with wireless ECG streamlines data collection in clinical trials.
  • Clario's $10 billion IPO filing indicates strong market interest and growth potential.

What critics are saying

  • Integration challenges may arise from Clario's acquisitions of NeuroRx and WCG's eCOA business.
  • AI partnership with PathAI could face algorithmic bias and data privacy concerns.
  • Wireless ECG device reliability and data security pose risks to trial outcomes and trust.

What makes Clairo unique

  • Clario offers a broad endpoint technology platform for diverse clinical trial models.
  • Trial Anywhere™ enables decentralized, hybrid, and site-based clinical trials with rich evidence.
  • Clario's 50 years of experience and 870 regulatory approvals enhance its credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Company News

Fierce Biotech
Mar 18th, 2025
Clario continues acquisition spree with imaging specialist NeuroRx

NeuroRx founder and CEO Douglas Arnold, M.D., is also joining Clario as a senior scientific advisor, Clario announced in a March 17 release.

PE Hub
Mar 17th, 2025
PE-backed Clario picks up medical research firm NeuroRx

Clario, a Philadelphia-based provider of endpoint data solutions to the clinical trial industry, has acquired NeuroRx, a Montreal-based provider of imaging analysis on multiple sclerosis.

CityBiz
Mar 17th, 2025
Clario Acquires NeuroRx for Imaging Expertise

Clario, a leader in endpoint data solutions for clinical trials, has acquired NeuroRx, an imaging analysis expert in multiple sclerosis. This acquisition enhances Clario's neuroscience capabilities. NeuroRx's founder, Douglas Arnold, M.D., will join Clario as Senior Scientific Advisor. Clario also plans to acquire WCG’s eCOA business, further strengthening its neuroscience expertise.

PR Newswire
Mar 10th, 2025
Clario Enters Into Definitive Agreement To Acquire Wcg'S Ecoa Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neurosciencePHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases

Clario
Oct 9th, 2024
Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

PHILADELPHIA - October 10, 2024 - Clario, a leading provider of endpoint data solutions to the clinical trials industry, is excited to announce a strategic partnership with PathAI, a leader in AI-powered digital pathology solutions aimed at improving diagnostic accuracy and efficiency.

INACTIVE